Abstract
The chimeric tyrosine kinase p210BCR – ABL is involved in the pathogenesis of chronic myelogenous leukemia. It transforms immature hematopoietic cells in vitro and abrogates IL-3-dependent growth. The mechanisms by which p210BCR – ABL mediates its oncogenicity are not well elucidated. Identifying transcription factors targeted by the chimeric protein may help to clarify these mechanisms. We have analysed the effect of p210BCR – ABL expression on NF-κB activity in DA1 cells (an IL-3-dependent murine myeloid progenitor cell line). A specific stimulation of NF-κB activity by kinase-active wild-type p210BCR – ABL has been evidenced by transcriptional activation assays. Electrophoretic mobility supershift assays revealed the presence of p65 protein (RelA) DNA binding activity in p210BCR – ABL transformed DA1 cells but not in parental DA1 cells. Activation of RelA in transformed DA1 cells may occur by protein stabilization. Experiments using oligonucleotides antisense to RelA showed that p210BCR – ABL transfected cells failed to survive after IL-3 removal. Moreover, inhibition of cellular growth was shown following treatment of p210BCR – ABL transformed DA1 cells by p65 antisense oligonucleotides. This study suggests that p65 NF-κB may be an effector for p210BCR – ABL and probably contributes to its induced transformation process.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hamdane, M., David-Cordonnier, MH. & D'Halluin, J. Activation of p65 NF-κB protein by p210BCR – ABL in a myeloid cell line (P210BCR – ABL activates p65 NF-κB). Oncogene 15, 2267–2275 (1997). https://doi.org/10.1038/sj.onc.1201411
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1201411
- Springer Nature Limited
Keywords
This article is cited by
-
Eliminating chronic myeloid leukemia stem cells by IRAK1/4 inhibitors
Nature Communications (2022)
-
Inhibition of cystathionine β-synthase promotes apoptosis and reduces cell proliferation in chronic myeloid leukemia
Signal Transduction and Targeted Therapy (2021)
-
Clonal competition in BcrAbl-driven leukemia: how transplantations can accelerate clonal conversion
Molecular Cancer (2017)
-
A regulation probability model-based meta-analysis of multiple transcriptomics data sets for cancer biomarker identification
BMC Bioinformatics (2017)
-
NF-κB suppresses ROS levels in BCR–ABL+ cells to prevent activation of JNK and cell death
Oncogene (2011)